VP Sorbara’s NIH Research Project Highlighted at Conference

Pictured at the AACR conference are AMHS VP Lynn Sorbara (2nd from left) and colleagues on the Liquid Biopsy Consortium.

The work of AMHS Second Vice President,

Lynn Sorbara and her team at the Nation al Institutes of Health (NIH) on ground breaking cancer research continues to earn notice. , She along with her colleague, Dr. Sudhir Srivastava, conducted a lecture and discussion session at the American Association for Cancer Research Conference on April 2, and the infor mation was picked up by CNN. One of the Grant ees in her Consortium, Dr. Nick Papadopoulos of Johns Hopkins University, was interviewed.

She said CNN even used her pet phrase to describe the goals they have as “The Holy Grail.” According to the CNN article, “Testing for cancer in blood, urine or even saliva: That approach has been called the ‘holy grail’ for diagnosing the second leading cause of death in the world. “For the future, many cancer researchers are exploring whether a cancer test could involve only collecting and analyzing a sample of your blood, saliva or urine so that it’s noninvasive, cheaper and more appealing to patients — espe cially when trying to diagnose cancer early.

“The science behind detecting signs of cancer in liquid biopsies — and how that could change the patient experience and public health as a whole — remains in the early, experimental stages but has spurred some excitement.” Lynn is currently the program director for the Cancer Biomarker Research Group in the Divi sion of Cancer Prevention of the National Cancer Institute (NCI) of the National Insti tutes of Health (NIH). Brava, Lynn. We are all very proud of you! ❚